Sandy Spring Bank’s Medifast MED Stock Holding History

Sandy Spring Bank’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-160	Closed	-$6.13K	–	1306
2024 Q1	$6.13K	Hold	160	–	–	﹤0.01%	934
2023 Q4	$10.8K	Hold	160	–	–	﹤0.01%	805
2023 Q3	$12K	Hold	160	–	–	﹤0.01%	792
2023 Q2	$14.7K	Hold	160	–	–	﹤0.01%	767
2023 Q1	$16.6K	Hold	160	–	–	﹤0.01%	733
2022 Q4	$18.5K	Hold	160	–	–	﹤0.01%	713
2022 Q3	$17K	Hold	160	–	–	﹤0.01%	705
2022 Q2	$29K	Sell	160 -30	-16%	-$5.37K	﹤0.01%	625
2022 Q1	$32K	Hold	190	–	–	﹤0.01%	629
2021 Q4	$40K	Sell	190 -10	-5%	-$2.07K	﹤0.01%	621
2021 Q3	$39K	Hold	200	–	–	﹤0.01%	615
2021 Q2	$57K	Hold	200	–	–	﹤0.01%	538
2021 Q1	$42K	Hold	200	–	–	﹤0.01%	542
2020 Q4	$39K	Hold	200	–	–	﹤0.01%	537
2020 Q3	$33K	Hold	200	–	–	﹤0.01%	524
2020 Q2	$28K	Hold	200	–	–	﹤0.01%	546
2020 Q1	$13K	Hold	200	–	–	﹤0.01%	635
2019 Q4	$22K	Hold	200	–	–	﹤0.01%	605
2019 Q3	$21K	Hold	200	–	–	﹤0.01%	611
2019 Q2	$26K	Buy	+200	New	+$27.8K	﹤0.01%	567

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Sandy Spring Bank's MED Position: Q2 2024 in Review

Sandy Spring Bank sold out of Medifast (MED) in Q2 2024, closing a stake of 160 shares — an estimated $6.13K sold.

Sandy Spring Bank first reported a position in MED in Q2 2019 and held it in 20 quarters. The position peaked at $57K in Q2 2021. 158 funds tracked by Wall St. Rank hold MED as of Q2 2024.

Sandy Spring Bank reported no remaining Medifast position as of Q2 2024 after selling out during the quarter.
Sandy Spring Bank sold 160 Medifast shares in Q2 2024, an estimated $6.13K.
Sandy Spring Bank first reported a position in Medifast in Q2 2019 and held it in 20 quarters.
Sandy Spring Bank's Medifast position peaked at $57K in Q2 2021.
158 funds tracked by Wall St. Rank held Medifast as of Q2 2024.

Based on Sandy Spring Bank's 13F filing for Q2 2024, filed 6 Aug 2024.